Skip to content
中文产业新闻精选评分59Chinese source

劲方医药GFH375治疗KRAS G12D突变型NSCLC II期数据入选2026 WCLC口头报告

WCLC Oral | GFH375单药治疗经治KRAS G12D突变型NSCLC II期优效数据入选2026世界肺癌大会口头报告

Original articleChinese edition

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.